Reversion of recent-onset atrial fibrillation to sinus rhythm by intravenous flecainide
- 1 January 1991
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 67 (2), 137-141
- https://doi.org/10.1016/0002-9149(91)90435-n
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillationThe American Journal of Cardiology, 1987
- Digoxin for Converting Recent-Onset Atrial Fibrillation to Sinus RhythmAnnals of Internal Medicine, 1987
- Flecainide acetate for conversion of acute supraventricular tachycardia to sinus rhythmThe American Journal of Cardiology, 1987
- FlecainideNew England Journal of Medicine, 1986
- Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibersJournal of the American College of Cardiology, 1985
- Clinical Usefulness of Flecainide Acetate in the Treatment of Paroxysmal Supraventricular ArrhythmiasDrugs, 1985
- Effect of Intravenous Flecainide on Atrial Vulnerability in ManDrugs, 1985
- Cardioversion with flecainide in patients with atrial fibrillation of recent onsetEuropean Journal of Clinical Pharmacology, 1985
- Effects of flecainide on ventricular function: Clinical and experimental correlationsThe American Journal of Cardiology, 1984
- Acute electrophysiological effects of flecainide acetate on cardiac conduction and refractoriness in man.Heart, 1982